Search page

A Regulatory Risk haplotype in HLA-DQ region regulates antigen presentation of monocyte in Type 2 inflammation in chronic rhinosinusitis with nasal polyps

ANCHOR-1 and 2 Study Design: Replicate Phase 3 Randomised, Double-Blind, Placebo-Controlled Studies of the Efficacy and Safety of Depemokimab in Patients with Chronic Rhinosinusitis with Nasal Polyps

Advancements and Key Insights in Chronic Rhinosinusitis (CRS) Management

Allergen Immunotherapy decreases biologicals use in allergic rhinitis with chronic rhinosinusitis with nasal polyps (CRSwNP)

Anti-thymic stromal lymphopoietin CM326 for uncontrolled chronic rhinosinusitis with nasal polyps: a randomized, double-blind, placebo-controlled phase 1b/2a trial

Artificial intelligence-assisted prediction of olfactory disorders in patients with chronic rhinosinusitis

Baseline Disease Characteristics Among Patients with Chronic Rhinosinusitis with Nasal Polyps and Coexisting Asthma in the Global AROMA Registry

Biologics and rhinosinusitis with and without nasal polyps

Challenges in Biologics for Chronic Rhinosinusitis with Nasal Polyps

Changes in pathological characteristics and influence factors of chronic rhinosinusitis in the Greater Bay Area of China: A retrospective study on whole slide image-based of artificial intelligence

Characteristics of patients with chronic rhinosinusitis with nasal polyps and allergic rhinitis enrolled in the global AROMA registry

Characterization of chronic rhinosinusitis patients based on markers of type 2 inflammation: Findings from the European CRS Outcome Registry (CHRINOSOR)

Chronic Rhinosinusitis

Chronic rhinosinusitis among young adults is strongly associated with atopy and signs of type-1 inflammation

Chronic rhinosinusitis with nasal polyposis: an old problem with a new solution

Clinical Implication of Neutrophil Phenotypes in Chronic Rhinosinusitis With Nasal Polyps

Clinical and Treatment Characteristics of Patients with Chronic Rhinosinusitis with Nasal Polyps by Treating Physician Specialty: Results from an EU Chart Review Study

Concepts and Pathology of Eosinophilic Rhinosinusitis

Construction of prediction model for olfactory dysfunction improvement in patient with chronic rhinosinusitis after endoscopic sinus surgery

Correlation of chronic rhinosinusitis and lung function in allergy patients with chronic cough

CosMx™ single cell spatial imaging identifies changes in spatial cell communication in chronic rhinosinusitis with nasal polyps following anti – IL-5 treatment

Deep immune profiling of chronic rhinosinusitis in allergic and non-allergic cohorts using mass cytometry

Design of a phase 3, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of tezepelumab in adult patients with severe chronic rhinosinusitis with nasal polyposis (WAYPOINT)

Determinants of Adherence of Biologic Therapies in Chronic Rhinosinusitis

Distribution of Baseline Type 2 Inflammation Characteristics in Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) Biologic Clinical Trials: A Comparative Assessment

Doxycycline therapy reduced local nasal inflammation and promoted wound healing after FESS in Chronic Rhinosinusitis patients

Dual monoclonal antibody therapy in a patient with chronic rhinosinusitis with nasal polyps and severe eosinophilic asthma: a case report and proteome analysis

Dupilumab Restores Barrier Function of Nasal Epithelial Cells and Decreases Type-2 Inflammatory Markers in Chronic Rhinosinusitis with Nasal Polyps

Dupilumab Treatment is Associated with Clinical Improvement and a Shift towards a health-associated Nasal Passage Microbiota in Diffuse Type 2 Chronic Rhinosinusitis

Dupilumab alleviates the abnormal differentiation of club cells induced by IL-13 in chronic rhinosinusitis with nasal polyps

Dupilumab-induced eosinophilia in patients with diffuse type 2 chronic rhinosinusitis

Dupilumab-induced skin reaction in a patient with severe asthma and chronic rhinosinusitis with nasal polyposis and without prior skin conditions

Early Responders within One Month of Dupilumab Treatment for Chronic Rhinosinusitis with Nasal Polyps

Effect of Dupilumab on Radiological Remission in Patients with Chronic Rhinosinusitis with Nasal Polyp: A step Toward Clinical Remission

Effect of anti IL-5/IL-5Rα biological treatment on tissue eosinophil subpopulations in patients affected by Chronic Rhinosinusitis with Nasal Polyp

Effectiveness and Safety of Dupilumab in patients with chronic rhinosinusitis with nasal polyps After One Year of Therapy: Results from a real-world non-interventional study in Germany (ProGNOSE)

Effects of Dupilumab on Eosinophil Subpopulations and Inflammation in Chronic Rhinosinusitis with Nasal Polyps

Efficacy and safety of tezepelumab in adults with severe chronic rhinosinusitis with nasal polyps overall and in patients with and without co-morbid asthma: results from the phase 3 WAYPOINT study

Efficacy of Dupliuzumab in the treatment of atopic dermatitis complicated by chronic rhinosinusitis with nasal polyps

Efficacy of Omalizumab in Refractory Chronic Rhinosinusitis with Nasal Polyps and Association with Local Immunoglobulin E

Emerging Biologic Use May Reduce the Need for Corticosteroid Treatment and Surgery for Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) in France, Germany, Italy, Spain and the UK

Endotyping chronic rhinosinusitis for a better treatment approach

Enhanced Production of CEACAM5 And Its Association With Increased Plasma Cell Infiltration In Chronic Rhinosinusitis With Nasal Polyps

Eosinophilic Chronic Rhinosinusitis with Nasal Polyps : Current Perspective

Evaluating ChatGPT’s Performance in Answering Questions About Allergic Rhinitis and Chronic Rhinosinusitis

Evaluation of Early Real-World Efficacy and Safety of Mepolizumab in Chronic Rhinosinusitis with Nasal Polyposis Through a Multidisciplinary Approach

Frequency and impact of chronic rhinosinusitis on allergic rhinitis: a retrospective multicenter cohort study with long term follow-up

Hippo-YAP inhibits the autophagic degradation of Cyclin D1 in chronic rhinosinusitis with nasal polyps

Improved Quality of Life, Early Symptom Control and Reduced Surgery with Mepolizumab in Chronic Rhinosinusitis with Nasal Polyps (CRSwNP): Results from the SYNAPSE Study

Improvement in Olfactory Training for Postoperative Olfactory Dysfunction in Chronic Rhinosinusitis with Nasal Polyps

Incidence of allergic rhinitis in different age group rhinosinusitis

Initiation of dupilumab led to reduced use of corticosteroids and antibiotics over 12 months in patients with chronic rhinosinusitis with nasal polyps treated in US real world practice

Inotodiol attenuates mucosal inflammation in a mouse model of eosinophilic chronic rhinosinusitis

Is Chronic Rhinosinusitis Still an Underestimated Disease?

Local nasal inflammation and postoperative wound healing is improved by postoperative doxycycline therapy after FESS in Chronic Rhinosinusitis patients

Longitudinal Assessment of Dupilumab’s Therapeutic Effects in Chronic Rhinosinusitis with Nasal Polyps

Mental health, sexual functionality, quality of life, and patient experiences with chronic rhinosinusitis with nasal polyps at UNIMEQ-ORL in Bogotá, Colombia, 2022-2024: a mixed-methods study

Modulation of eosinophilic and neutrophilic inflammation in patients with chronic rhinosinusitis with nasal polyps treated with dupilumab, assessed by nasal cytology and biopsy histology

Nasal microbiome in chronic rhinosinusitis

Nasal polyp CD62Llow eosinophils as a prognostic biomarker of chronic rhinosinusitis with nasal polyp severity and predictive biomarker of mepolizumab and dupilumab response

Outcomes in chronic rhinosinusitis and type 2 inflammation

PROMs Improvement Effects of Biologics in Chronic Rhinosinusitis with Nasal Polyps Patients: Real-life Experience

Pathological Characteristics of Chronic Rhinosinusitis and Their Association with Urbanization: A Retrospective Study Based on Whole-Slide Scanning Using Artificial Intelligence

Patients with Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) and Comorbid Asthma Experience Early and Sustained Benefit with Depemokimab in the Randomised, Double-Blind, Parallel-Group, Replicate ANCHOR-1/2 Studies

Performance of 5 item and 22 item sino-nasal outcome tests in response to dupilumab in chronic rhinosinusitis with nasal polyps

Phenotypes and inflammatory molecular endotypes of chronic rhinosinusitis and its implication for asthma

Platycodon D protects human nasal epithelial cells from pyroptosis through the Nrf2/HO-1/ROS signaling cascade in chronic rhinosinusitis

Postoperative Anti-IgE Therapy for Chronic Rhinosinusitis with Nasal Polyps and Asthma: Efficacy and Prognostic Factors

Predictive model for postoperative unrecovered olfactory function in chronic rhinosinusitis patients with olfactory disorder

Proteomic analysis identifies patients with chronic rhinosinusitis with nasal polyps who are responders and non-responders to benralizumab (NAPPREB study)

REALITI-N: First Ambidirectional Cohort Study Evaluating Real-World Mepolizumab Use in Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)

Real-Life Effectiveness of Mepolizumab and Omalizumab in Sever Uncontrolled Chronic Rhinosinusitis with Nasal Polyps: A Prospective Study

Real-Life Effectiveness of Monoclonal Antibody Therapy in Severe Uncontrolled Chronic Rhinosinusitis with Nasal Polyps: A Prospective Study

Real-Life effectiveness of a Cohort of Patients with Chronic Rhinosinusitis with Nasal Polyposis (CRSwNP) and Concomitant Moderate Persistent Asthma Treated with Dupilumab

Real-world data show sustained therapeutic effects of dupilumab in chronic rhinosinusitis with nasal polyps (CRSwNP) over 3 years

Real-world effectiveness of dupilumab in patients with chronic rhinosinusitis with nasal polyps (CRSwNP) is independent of comorbidities, sinus surgery history and level of type 2 inflammation: Findings from CHRINOSOR

Regulatory T cells act as the guardians of mucosal immune homeostasis in chronic rhinosinusitis

Rhinosinusitis

SLC27A2 marks lipid peroxidation in nasal epithelial cells driven by type 2 inflammation in chronic rhinosinusitis with nasal polyps

SNOT-22 and olfactory perception in Chronic Rhinosinusitis with Nasal Polyps: A Retrospective Observational Study

Sequence of improvements in objective and patient-reported outcomes with dupilumab treatment in patients with chronic rhinosinusitis with nasal polyps: Analysis of the SINUS-52 study

Stapokibart for severe uncontrolled chronic rhinosinusitis with nasal polyps: multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase 3 trial

Study of olfaction in patients with chronic rhinosinusitis with nasal polyposis undergoing Mepolizumab treatment

Tezepelumab reduces OCS use and improves sino-nasal symptoms in OCS-dependent patients with severe asthma and comorbid chronic rhinosinusitis (overall and with nasal polyps): results from the phase 3b WAYFINDER study

The Clinical Characteristics and Inflammatory Endotypes of Chronic Rhinosinusitis with Nasal Polyps in Southern China: A Multi-Center, Cross Section study

The Influence of Dupilumab on the Nasal and Gastrointestinal Microbiome in Diffuse Type 2 Chronic Rhinosinusitis

The Relationship Between Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) and Serum Mas-Related G-Protein Coupled Receptor-X2 (MRGPRX2) Level

The Role of Rho GTPase Signaling on Epithelial-Mesenchymal Transition and Inflammation of Chronic Rhinosinusitis with Nasal Polyp

The correlation between chronic rhinosinusitis with/without nasal polyp and chronic kidney disease: a longitudinal follow-up study

The impact of intranasal corticosteroids on exhaled nitric oxide in chronic eosinophilic rhinosinusitis with nasal polyposis after surgery

The impact of secretory IgA on nasal microbiome control and its link to the development of chronic rhinosinusitis

The multi-omics single-cell landscape of sinus mucosa in uncontrolled severe chronic rhinosinusitis with nasal polyps

The role of anosmia in predicting biologic responsiveness for Chronic Rhinosinusitis with Nasal Polyposis

The upper airway microbiome – potential target in chronic rhinosinusitis

Understanding and managing Chronic Rhinosinusitis with Nasal Polyps

Unveiling the Prevalence and Impact of Silent Rhinovirus Infection in Chronic Rhinosinusitis with Nasal Polyps

Welcome

Only match titles

What are you looking for?

Knowledge Hub

Website

Only match titles

What are you looking for?

Knowledge Hub

Event Resources

Covid-19

Courses

Books

Guidelines

Position Papers

Website

Sessions